HIV and Hepatitis.com - HIV and AIDS Main Page

HIV and AIDS Main Section
FDA-approved Treatments Experimental Treatments Top New Articles

Supported by an
Educational Grant from Tibotec herapeutics

Part 1 | Part 2

HIV and AIDS Top News Articles
Persistent AIDS-related Kaposi Sarcoma in the HAART Era Reveals Need for New Therapies - 5/09/08
HIV Prevalence Dramatically Impacts the Number of New Tuberculosis Cases and Deaths - 5/09/08
Rapid Scale-up of Antiretroviral Therapy in South Africa Could Reduce HIV/AIDS Deaths by 1.3 Million by Year 2012 - 5/09/08
Higher CD4 Count Predicts Lower Risk of AIDS-related and Non-AIDS Illness, even above 350 Cells/mm3 - 5/06/08
Patients with CXCR4-tropic or Mixed-tropic HIV Experience Faster CD4 Cell Decline and May Benefit from Earlier Treatment - 5/06/08
NIAID Research Priorities to Fight Drug-resistant Tuberculosis - 5/06/08
Treatment Options for Osteopenia and Osteoporosis in HIV Patients - 5/02/08
*HLA B5701 Genetic Test Predicts Abacavir Hypersensitivity in Black as well as White HIV Patients - 5/02/08**
Genetic Variation Predicts Higher Risk of Lipoatrophy in Patients on HAART - 5/02/08
Interrupting Antiretroviral Therapy Does Not Reduce the Risk of Cardiovascular Disease: Final Results of ACTG 5102 - 4/29/08
Tolerability and Effectiveness of First-line Treatment with Nevirapine and Lamivudine plus Zidovudine or Stavudine - 4/29/08
Efficacy and Safety of Once-daily Regimens in the Treatment of HIV Infection - 4/24/08
Following Antiretroviral Treatment Guidelines Produces the Best Results in Women with HIV - 4/24/08
Interactions between the Anti-fungal Agent Voriconazole (Vfend) and Antiretroviral Drugs- 4/24/08
Researchers Develop Breath Analyzer to Monitor Treatment Adherence - 4/24/08
Selected Highlights from the 9th International Workshop on Clinical Pharmacology of HIV Therapy - 4/18/08
CD4 Cell Recovery after Initiation of HAART in Treatment-naive Patients - 4/18/08
Fish Oil with or without Fenofibrate Reduces Elevated Triglycerides in HIV Patients on HAART - 4/18/08
Certain Maternal and Child HLA Patterns Increase Risk of Vertical HIV Transmission - 4/18/08
Schering-Plough Initiates Phase II Study with Vicriviroc in Treatment-na�ve HIV-infected Patients - 4/16/08
Resistance Profile of the New Protease Inhibitor Darunavir (Prezista) - 4/15/08
Elevated Fibrinogen Levels Linked to Protease Inhibitors May Contribute to Elevated Cardiovascular Risk - 4/15/08
Anti-inflammatory Drug Salsalate May Improve Blood Vessel Dysfunction in People with HIV - 4/15/08
New Report Says 2.1 Million Children Worldwide Are Living with HIV/AIDS - 4/15/08
European Symposium on Patient Compliance and Persistence (ESPACOMP) Set for September 5, 2008 in Basel, Switzerland - 4/15/08
Management of HIV Positive Men with Prostate Cancer in the HAART Era - 4/11/08
Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People - 4/11/08
Lower-Strength Lopinavir/Ritonavir (Kaletra, Aluvia) Tablet Approved in Europe for Children with HIV - 4/11/08
Federal Government Announces $1.1 Billion in Ryan White Grants for HIV/AIDS Care and Services - 4/11/08
Report Examines Progress and Challenges Facing State AIDS Drug Assistance Programs (ADAPs) - 4/11/08
"Women Living Positive: It's My Life" National Summit Webcast - 4/11/08
Human Genetic Variations Predict Response to Antiretroviral Therapy - 4/04/08
Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children - 4/04/08
New amFAR Survey Reveals HIV Positive Women Still Face Stigma - 4/04/08
Argos Therapeutics Reports Promising Phase 1 Data on AGS-004 Immunotherapy for HIV - 4/04/08
Is There a Potential Role for Ritonavir-boosted Protease Inhibitor Monotherapy? - 4/01/08
TMP-SMX Remains the Therapeutic Drug of Choice for HIV-related PCP in First- and Second-line Settings - 4/01/08
Latest CDC Figures Show More Diagnosed HIV Cases, but Not More New Infections - 4/01/08
New Network Will Send Drug Alerts Instantly to U.S. Doctors via Email - 4/01/08
FDA Issues Safety Review of Ziagen and Videx; GlaxoSmithKline Responds - 3/28/08
Registration Opens for 17th International AIDS Conference (AIDS 2008) in Mexico City, August 3-8, 2008 - 3/28/08
U.S. Government-sponsored HIV Vaccine Research Faces Setbacks - 3/28/08
Tenofovir (Viread) Is Better Tolerated than AZT (Retrovir) as Part of a Post-exposure Prophylaxis Regimen - 3/28/08
Cost Effectiveness of Truvada versus Combivir, Both in Combination with Efavirenz (Sustiva) - 3/28/08
New Pediatric Dosing Recommendations for Atazanavir (Reyataz) - 3/28/08
FDA Warns Consumers Not to Use Products Sold Over the Internet for Erectile Dysfunction - 3/28/08
Nevirapine (Viramune) versus Abacavir (Ziagen) in Combination with AZT/3TC (Combivir) as First-line Antiretroviral Therapy - 3/21/08
Determinants of HIV Progression and Assessment of Optimal Time to Start HAART: PISCIS Study - 3/21/08
Anal Cancer Risk Remains High among HIV Positive Men and Women on HAART: SUN Study - 3/21/08
Efficacy and Safety of Dual Protease Inhibitor Regimens for the Treatment of Antiretroviral-naive HIV Patients - 3/18/08
NNRTI-based Therapy Yields High Response Rates despite Prior Exposure to Single-dose Nevirapine (Viramune) - 3/18/08
Antiretroviral Therapy Is Not a Risk Factor for Hypogonadism in HIV Positive Men - 3/18/08
U.S. Syphilis Rate Rises for 7th Year in a Row, Testing Is Inadequate for Gay and Bisexual Men, and STD Rates Are High among Young Women - 3/18/08
Second Study Fails to Show Benefit of Herpes Treatment for Preventing HIV Infection - 3/18/08
Low Levels of HIV Persist for at Least 7 Years despite Effective Antiretroviral Therapy - 3/14/08
Growth Hormone May Boost Thymic Function and Increase CD4 Cell Count - 3/14/08
Growth Hormone and GH Releasing Factor (Tesamorelin) for HIV-related Lipodystrophy - 3/14/08
FDA Warns Companies Selling Drugs on the Internet that Falsely Claim to Prevent and Treat STDs, including HIV/AIDS - 3/14/08
Tibotec and FDA Warn of Liver Toxicity Linked to Ritonavir-boosted Darunavir (Prezista) - 3/12/08
Maraviroc (Selzentry) Has Minimal Effect on Lipid Profiles - 3/11/08
100 mg Once- and Twice-daily Ritonavir (Norvir) Decreases HDL and CD36 Expression, but Only Twice-daily Dosing Increases Triglycerides - 3/11/08
CDC Publishes New Website Section on HIV/AIDS in People Aged 50 and Older - 3/11/08
NIAID Statement on National Women and Girls HIV/AIDS Awareness Day - 3/11/08
Balm In Gilead Mobilizes Black Church Week of Prayer for the Healing of AIDS - 3/11/08
Study of HIV Positive Veterans on HAART Shows No Elevated Cardiovascular Risk - 3/07/08
Boosted Darunavir (Prezista) Is Safe and Effective for Children with HIV - 3/07/08
Panacos Announces Data from Phase 2b Trial of HIV Maturation Inhibitor Bevirimat (PA-457) - 3/07/08
NGX-4010 Skin Patch Does Not Reduce HIV-related Neuropathy Pain More than Placebo - 3/07/08
Advocates Urge More Funding and Research for Rectal Microbicides - 3/07/08
Updated Treatment Guidelines for Children with HIV - 3/04/08
Antiretroviral Regimen Should Be Modified Promptly after Virological Failure - 3/04/08
Do CCR5 Antagonists Boost CD4 Cell Counts More than Other Antiretroviral Drug Classes? - 3/04/08
More Questions than Answers from STEP HIV Vaccine Trials - 3/04/08
NIAID Expresses Concerns about Potency of Abacavir/3TC (Epzicom) among Patients with High Viral Loads in ACTG Trial - 2/29/08
Second Virological Failure on Antiretroviral Therapy Is Now Less Common, but Still Hazardous - 2/29/08
Discordant Virological and Immunological Response to HAART Raises Risk of Disease Progression - 2/29/08
Tenofovir Gel Microbicide Safe for Daily Use in Women; Efficacy Studies Pending - 2/29/08
Tenofovir/Emtricitabine Pre-exposure Prophylaxis Prevents Rectal Transmission of HIV-like Virus in Monkeys - 2/29/08
New 600 mg Darunavir (Prezista) Formulation Allows for Fewer Pills per Dose - 2/29/08
Delaying HAART during Opportunistic Infection Treatment Leads to Disease Progression and Death - 2/26/08
Re-emergence of Drug-resistant Tuberculosis in HIV Positive People Is Due to Re-infection, Not Treatment Failure - 2/26/08
Lipodystrophy and Body Weight Changes in the Swiss HIV Cohort Study, 2000-2006 - 2/26/08
Effect of Enfuvirtide (Fuzeon) on Adherence to and Efficacy of Antiretroviral Therapy - 2/26/08